financetom
Business
financetom
/
Business
/
Hedge fund Cinctive up 11% in first half of the year - source
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hedge fund Cinctive up 11% in first half of the year - source
Jul 3, 2024 7:20 AM

NEW YORK, July 3 (Reuters) - U.S.-based hedge fund

Cictive Capital Management ended the first half of the year up

11%, mainly helped by its performance in equities, a source

familiar with the matter said.

Cinctive, a multi-strategy hedge fund with roughly $3

billion in assets under management, had gains with bets related

to artificial intelligence in sectors such as energy, technology

and utility stocks, the source added. Financials, healthcare and

biotech were also successful bets in the first half of the year.

Cinctive's performance beat other big multi-strategy hedge

funds, such as Citadel and Millennium.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nvidia CEO Huang sees strong demand for Blackwell chips
Nvidia CEO Huang sees strong demand for Blackwell chips
Nov 7, 2025
HSINCHU, Taiwan, Nov 8 (Reuters) - Nvidia ( NVDA ) CEO Jensen Huang said on Saturday the company is experiencing very strong demand for its Blackwell chips. Huang told reporters that business was growing strongly and there would be shortages of different things. ...
Nvidia CEO Huang sees strong demand for Blackwell chips
Nvidia CEO Huang sees strong demand for Blackwell chips
Nov 7, 2025
HSINCHU, Taiwan (Reuters) -Nvidia ( NVDA ) CEO Jensen Huang said on Saturday the semiconductor giant's business was growing strongly and it was experiencing very strong demand for its state-of-the-art Blackwell chips. Nvidia ( NVDA ) builds the GPU (graphics processing units), but we also build the CPU (central processing units), the networking, the switches, and so there are a...
Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer
Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer
Nov 7, 2025
Revised transaction values Metsera at up to $86.25 per share Metsera's ( MTSR ) Board of Directors unanimously recommends that Metsera ( MTSR ) stockholders approve the adoption of the amended Pfizer merger agreement and approve the merger with Pfizer Transaction creates real, certain and immediate value for Metsera's ( MTSR ) stockholders and ensures Metsera's ( MTSR ) important drug...
Metsera enters merger agreement with Pfizer
Metsera enters merger agreement with Pfizer
Nov 7, 2025
Nov 7 (Reuters) - Metsera ( MTSR ), an obesity drug developer, said on Friday that it has entered into an amended merger agreement with Pfizer ( PFE ), in which the New York-based company will acquire Metsera ( MTSR ) for up to $86.25 per share. Metsera's ( MTSR ) board has recommended that its shareholders approve the adoption...
Copyright 2023-2026 - www.financetom.com All Rights Reserved